These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 684322)
1. [Poly-immunotherapy anti-cancer in man]. de Sá CA; Ismael C; Miguez LA; Pereira Mde L; Leão Sde S; Fernandes ZZ Rev Hosp Clin Fac Med Sao Paulo; 1978 Jun; 33(3):167-73. PubMed ID: 684322 [No Abstract] [Full Text] [Related]
2. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)]. Ogura T Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203 [No Abstract] [Full Text] [Related]
3. Introduction: Immunotherapy of cancer in man, a reality. Klein E Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961 [No Abstract] [Full Text] [Related]
4. [Immunotherapy of cancer]. Gil Extremera B Rev Clin Esp; 1976 Aug; 142(3):281-91. PubMed ID: 788067 [No Abstract] [Full Text] [Related]
5. [Current status of immunotherapy in neoplasms]. Diaz-Rubio García E Rev Clin Esp; 1975 Dec; 139(6):487-96. PubMed ID: 766120 [No Abstract] [Full Text] [Related]
6. Study on cellular immunity of cancer patients treated with BCG. Onami K; Nanamiya M; Ohara M; Yoshida H; Kasukawa R Fukushima J Med Sci; 1982; 28(3-4):119-28. PubMed ID: 7186871 [No Abstract] [Full Text] [Related]
7. Immunotherapy: new hope for the cancer patient. Costanzi JJ; Goldstein AL Am Fam Physician; 1973 Nov; 8(5):150-4. PubMed ID: 4542856 [No Abstract] [Full Text] [Related]
8. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer. Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665 [No Abstract] [Full Text] [Related]
9. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy. Mathé G; Halle-Pannenko O; Bourut C Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738 [No Abstract] [Full Text] [Related]
10. [Paraspecific reactions of antigens: active immunotherapy of tumors. A review]. Hochstein-Mintzel V Fortschr Med; 1976 Oct; 94(28):1565-70. PubMed ID: 61935 [No Abstract] [Full Text] [Related]
11. BCG in bladder cancer. Meek D Nurs Times; 1994 Oct 26-Nov 1; 90(43):34-5. PubMed ID: 7984457 [TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of cancers]. Longpré B; Pleszczynski M Union Med Can; 1978 May; 107(5):485-91. PubMed ID: 664095 [No Abstract] [Full Text] [Related]
13. Is there a role for immunotherapy in the treatment of human cancer? Currie G Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):442-4. PubMed ID: 274008 [No Abstract] [Full Text] [Related]
14. BCG in cancer and leukemia treatment and prophylaxis-A review. Rosenthal SR J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732 [TBL] [Abstract][Full Text] [Related]
15. Letter: BCG in cancer treatment. N Engl J Med; 1974 Feb; 290(6):342-3. PubMed ID: 4809288 [No Abstract] [Full Text] [Related]
16. Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-Guérin. Richman SP; Gutterman JU; Hersh EM; Burgess MA; Mavligit GM Cancer Treat Rep; 1977; 61(3):471-2. PubMed ID: 872144 [No Abstract] [Full Text] [Related]
17. Complications of BCG immunotherapy in patients with cancer. Sparks FC; Silverstein MJ; Hunt JS; Haskell CM; Pilch YH; Morton DL N Engl J Med; 1973 Oct; 289(16):827-30. PubMed ID: 4763426 [No Abstract] [Full Text] [Related]
18. Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer. Sosnowski JT Compr Ther; 1994; 20(12):695-701. PubMed ID: 7882653 [No Abstract] [Full Text] [Related]
19. Improving the body's anticancer system. Kent S Geriatrics; 1980 Feb; 35(2):122-9. PubMed ID: 7356587 [No Abstract] [Full Text] [Related]